Medicare is likely to pay for anticancer drugsBMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7346.1118/b (Published 11 May 2002) Cite this as: BMJ 2002;324:1118
- Fred Charatan
The US Congress looks set to provide cover for anticancer drugs under Medicare, the federal health insurance programme for Americans aged over 65.
A bill currently before the house looks likely to be passed this year. According to law makers and lobbyists, this would be a first step towards a prescription drug benefit for Medicare subscribers.
A compromise on drugs to treat cancer would help many elderly Americans who must often choose between expensive prescription drugs and groceries. More than a fifth of the 40 million Medicare beneficiaries …